This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02209/identifier/kegg-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02209/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02209/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02209/identifier/pubchem-substance/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02209/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/resource/drugbank/drug/DB02209/identifier/chemspider/
n7http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02209/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02209
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB02209 n14:DB02209
dcterms:title
Pyridoxine-5'-Phosphate
adms:identifier
n4:28803 n5:1026 n11:46505900 n12:PXP n13:1055 n15:DB02209 n16:C00627
n6:IUPAC-Name
n7:271B47E2-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B47E8-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B47E7-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B47E4-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B47E5-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B47E6-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B47E0-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B47E1-363D-11E5-9242-09173F13E4C5 n7:271B47DE-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B47DF-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B47EE-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B47EF-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B47E9-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B47EA-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B47EC-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B47EB-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B47ED-363D-11E5-9242-09173F13E4C5
n6:casRegistryNumber
447-05-2
n6:Bioavailability
n7:271B47F4-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B47F6-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B47F7-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B47F3-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B47F2-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B47F5-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B47E3-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B47F0-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B47F1-363D-11E5-9242-09173F13E4C5